![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 39, 36174-36180, September 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Microbiology and Immunology, William Randolph Hearst Microbiology Research Center, Weill Medical College of Cornell University, New York, New York 10021
Received for publication, February 27, 2002, and in revised form, July 3, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Telomerase is an RNA-protein complex responsible
for the extension of one strand of telomere terminal repeats. The
catalytic protein subunit of telomerase, known generically as
telomerase reverse transcriptase (TERT), exhibits significant
homology to reverse transcriptases (RTs) encoded by retroviruses and
retroelements. The mechanisms of telomerase may therefore be similar to
those of the conventional reverse transcriptases. In this report, we explore potential similarity between these two classes of proteins in a
region with no evident sequence similarity. Previous analysis has
implicated a C-terminal domain of retroviral RTs (known as the
"thumb" domain) in template-primer binding and in processivity control. The equivalent region of TERTs, although similar to one another, does not exhibit significant sequence homology to retroviral RTs. However, we found that removal of this region of yeast TERT similarly resulted in a decrease in the stability of telomerase-DNA complex and in the processivity of telomerase-mediated nucleotide addition. Moreover, the C-terminal domain of TERT exhibits a nucleic acid binding activity when recombinantly expressed and purified. Finally, amino acid substitutions of conserved residues in this region
of TERT were found to impair telomerase activity and
processivity. We suggest that mechanistic similarity between
telomerase and retroviral RTs may extend beyond the regions with
apparent sequence similarity.
Telomerase is a ribonucleoprotein that is responsible for
maintaining the terminal repeats of telomeres in most organisms (1). It
acts as an unusual reverse transcriptase
(RT),1 using a small segment
of an integral RNA component as template for the synthesis of the
dGT-rich strand of telomeres (2).
Telomerase activity has been characterized from a wide range of
organisms and genes encoding both the RNA and protein components of the
enzyme complex identified (for reviews see (3, 4)). Telomerase RNAs
found in ciliated protozoa, in addition to having a short templating
region, share a common secondary structure. Telomerase RNAs from yeast
and mammals are considerably larger, and within each group conserved
structural elements can be identified based on phylogenetic and
mutational analysis (5, 6). The catalytic reverse transcriptase protein
subunit (TERT), first purified from Euplotes aediculatus as
p123, was found to be homologous to Est2p, a yeast protein required for
telomere maintenance (7-9). Both proteins possess RT-like motifs,
alterations therein can cause inactivation of telomerase activity and
reduction in telomere lengths. Subsequently, homologs of TERT were
identified in Schizosaccharomyces pombe, human, mouse,
Tetrahymena, Oxytricha, and
Arabidopsis (10-17). Because co-expression of TERT and
telomerase RNA in vitro in the rabbit reticulocyte lysate
system suffices to reconstitute enzyme activity (18, 19), these two
subunits probably constitute the core of the enzyme complex. Several
telomerase-associated polypeptides have been identified using either
biochemical or genetic tools. Preliminary studies suggest that these
factors may participate in telomerase assembly, function, or regulation (20-24).
Extensive mutational analysis of TERT residues equivalent to those
located within functional motifs of conventional RTs supports an
overall conservation of basic catalytic mechanisms between these two
classes of enzymes. For example, the TERT analogues of RT residues
essential for catalysis are absolutely required for telomerase activity
and telomere maintenance (9, 18, 25-27). Conserved residues shown
previously to modulate RT processivity have been found to be important
determinants of telomerase processivity as well (28-30). In addition,
the same tyrosine residue in conserved motif A allows both TERT and RTs
to discriminate against incorporating ribonucleotides (31). However,
some other crucial RT residues (e.g. a Gln in motif B')
appear to be less important or even dispensable for telomerase function
(9). Together, these results suggest that despite the high degree of
sequence divergence (<20% sequence identity), TERT and conventional
RTs may possess very similar polymerization mechanisms.
In retroviral RTs, the region immediately C-terminal to the RT motifs
(known as the "thumb" domain) has been shown to be important in
template/primer binding and in processive nucleotide addition. Such
functions are readily comprehended in light of the structural disposition of the thumb domain, which comprises a bundle of three Yeast Strains, Plasmids, and Primer DNA--
The construction of
a Purification of and Assay for Yeast Telomerase--
Whole cell
extracts and IgG-Sepharose-purified telomerase were prepared as
described previously (29, 33-35). Each primer extension assay was
carried out using 20 µl of IgG-Sepharose pretreated with 4 mg of
protein extract and was initiated by the addition of a 15-µl mixture
containing 100 mM Tris·HCl, pH 8.0, 4 mM
magnesium chloride, 2 mM dithiothreitol, 2 mM
spermidine, primer oligodeoxynucleotides, and varying combinations of
labeled and unlabeled dGTP and dTTP. Primer extension products were
processed and analyzed by gel electrophoresis as described previously
(35, 36).
For the primer challenge experiment, the IgG-Sepharose-bound telomerase
was preincubated with 40 ng of TEL15(m12) primer at room temperature
for 15 min and then challenged with 400 ng of TEL24 primer. After 5, 15, and 40 min, labeled nucleotides (dTTP, 25 µCi) were added to
initiate the polymerization reaction. For the measurement of
enzyme-product stability, reactions were performed as described
previously. Upon termination, the IgG-Sepharose was washed three times
with 100 µl each of TMG-10 (150) buffer. The washes were pooled,
digested with proteinase K, and extracted with
phenol/chloroform/Isoamyl alcohol, and then the free products were
precipitated and analyzed along with the enzyme-bound products.
For kinetic analysis, primer extension assays were performed using
IgG-Sepharose-purified enzyme, varying concentrations of a 15-nt
primer, 50 µM unlabeled dGTP, and 25 µCi of
[
For determination of the processivity of substitution mutants, assays
were performed using TEL66 as primer. The signal for each product was
determined by PhosphorImager (Molecular Dynamics) and normalized to the
amount of transcript by dividing against the number of labeled
residues. The TEL66 primer ends in three Gs and can align to only one
site along the yeast RNA template, thus supporting the addition of a
defined sequence (TGTGGTG). The processivity for each position
(Pi) was calculated using the formula Pi = sum(Ti+1 + Ti+2 + ... + Tn)/sum(Ti + Ti+1 + ... + Tn), where Ti designates
the amount of transcript calculated for the primer + i position and
n designates the highest number such that a visible signal
can be discerned in the PhosphorImager file for the primer + n product.
Expression and Analysis of Recombinant CTE--
For expression
of the TERT CTE, a PCR fragment encoding amino acids 747-874 of Est2p
with flanking NdeI and XhoI sites was generated
and cloned into the corresponding sites in pTYB12 (New England
Biolabs). The resulting plasmid was transformed into BL21 cells. A
transformant was inoculated into L broth and grown under ampicillin
selection (50 µg/ml) at 37 °C overnight. A 10-ml culture of
saturated cells was then diluted with 1 liter of L broth containing ampicillin and grown at 37 °C for 2.5 h. When the
OD600 of the culture reached 0.5, the culture was cooled on
ice for 30 min, induced by the addition of
isopropyl-
Circular dichroism (CD) spectra were acquired on an Aviv 62DS (Aviv
Associates, Lakewood, NJ) CD spectropolarimeter equipped with a
computer-controlled water bath using a thermostated cuvette of 0.1-cm
path length. Measurements of [ Determination of Telomere Length--
Chromosomal DNA was
isolated using the "smash and grab" protocol, digested with
PstI, and electrophoretically separated on a 1% agarose
gel. Following capillary transfer to nylon membranes, telomere-containing fragments were detected by hybridization with a
32P-labeled poly(dG-dT) probe.
RNA and Protein Analysis--
The levels of Est2p-associated
TLC1 RNA were determined by an RNase protection assay. IgG-Sepharose
enriched telomerase was prepared as before and de-proteinated with SDS
and proteinase K treatment and phenol extraction. The remaining nucleic
acids were combined with an antisense probe (100,000 cpm) and
hybridized and digested as described previously (39). For synthesis of uniformly labeled RNA probe, the TLC1 gene (nucleotides 1-1301) (40)
was first amplified by PCR and cloned in between the BamHI and EcoRV site of pBluescript II KS+. The resulting plasmid
was linearized by digestion with HinfI, and antisense RNA
encompassing residues 1097-1301 of the TLC1 gene was generated by T3
RNA polymerase in the presence of 12 µM
[ Removal of the C-terminal Extension of TERT Causes a Reduction in
the Stability of Telomerase-DNA Interaction--
To probe the function
of the CTE, we generated a deletion mutant of Est2p (named C745) that
removed most of the amino acids beyond the last conserved RT motif
(Fig. 1A, motif E).
A yeast strain harboring this deletion mutant was severely defective in telomere maintenance, and telomerase isolated from the strain exhibits
a severe reduction in enzyme processivity (29). To further analyze the
enzymatic defects associated with the removal of CTE, we measured the
stability of telomerase-DNA binding using a primer-challenge assay. A
test primer (TEL15(m12)) was pre-bound to either wild type or
C745-containing telomerase followed by the addition of an excess of a
competitor primer (TEL24). A labeled nucleotide was then added after
various time intervals to initiate the extension reaction. The amounts
of reaction products arising from the test primer were then quantified.
As shown in Fig. 1, B and C, the challenge primer
was able to reduce polymerization on the test primer more quickly when
the C745 enzyme was used in the assays. Inspection of Fig.
1C indicates that the half-life of the telomerase-DNA
complex for the TEL15(m12) primer was reduced by ~2-fold by the
C-terminal truncation mutation (from about 2 to 1 min). These results
are consistent with a role for CTE in telomerase-DNA interaction.
We also measured the stability of telomerase-DNA binding after the
primer has been extended. For this analysis, we took advantage of the
stable association between protein A-tagged telomerase and
IgG-Sepharose. Reactions were performed in duplicates using the
TEL15(m12) primer. Upon termination of the reactions, the labeled
products were separated into soluble and Sepharose-bound fractions
before analysis in denaturing gels (Fig.
2A). The ratios of
enzyme-bound products to free products at each extension position were
then quantified. For ease of presentation, only the results for the
Primer + 3 (p + 3) and Primer + 5 (p + 5)
position are shown in Fig. 2B. At both positions, the C745
enzyme bound a smaller fraction of the reaction products than the wild
type enzyme, consistent with impaired telomerase-DNA interaction.
Similar results were obtained at other positions. It was also evident
from the analysis that for both the wild type and C745 enzyme, the
fraction of enzyme-bound products was higher at the p + 5 than at the p + 3 position, consistent with the ability of a
longer RNA-DNA hybrid to promote enzyme-DNA stability.
As yet another measure of telomerase-DNA interaction, we carried out
kinetic analysis of nucleotide addition for both the wild type and
mutant enzyme. Assays were performed using varying concentrations of a
primer oligonucleotide, and the results were analyzed by Eadie-Hofstee
plots. As shown in Fig. 3, A
and B, the Km for the C745 telomerase was
~2.5-fold higher than that for the wild type enzyme, consistent with
reduced binding of the primer to the truncated telomerase. Thus, by
three different criteria, the loss of the CTE of yeast TERT resulted in
a telomerase that binds less strongly to telomeric DNA.
The C-terminal Extension of TERT Can Bind Nucleic Acids--
To
determine whether the CTE of TERT can indeed bind nucleic acids as
would be expected for the thumb domain, we expressed amino acids
747-874 of yeast TERT as a fusion protein to an intein-CBD (chitin-binding domain) tag. The fusion protein was purified by adsorption to a chitin column, and the CTE was separated from the tag
by intein-mediated self-cleavage in the presence of dithiothreitol. For
unknown reasons, the CTE fragment remained bound to the column after
cleavage and could not be eluted even with high salt. We therefore
eluted the CTE fragment with urea. Following elution, the CTE was
purified further either with a reverse phase HPLC or an S-Sepharose
column. The HPLC preparation was lyophilized and solubilized in water,
whereas the S-Sepharose preparation was renatured by stepwise dialysis
into buffers containing reducing concentrations of urea. As shown in
Fig. 4A, both preparations are
nearly homogeneous. We then subjected the HPLC-purified fragment to
analytical ultracentrifugation and CD analysis. These studies revealed
a monomeric protein with high
The purified CTE was tested for its ability to interact with nucleic
acids using a nitrocellulose filter-binding assay. First, a
single-stranded 24-mer oligonucleotide with a telomere-like sequence
was assessed for binding. As shown in Fig. 4B, the
S-Sepharose-purified CTE exhibited concentration-dependent
binding to this oligonucleotide, whereas a control protein
(maltose-binding protein) did not. We then compared the ability of
single-stranded DNA, double-stranded DNA, and RNA-DNA hybrid (all with
telomere-like sequences) to bind CTE. Equal molar concentrations of the
different substrates were tested in filter-binding assays using the
same amount of CTE. Interestingly, as shown in Fig. 4C, CTE
appears to manifest a slight preference for double-stranded substrates
(~2-3-fold), consistent with its putative role in contacting an
RNA-DNA hybrid in the context of a telomerase-DNA complex. Analysis of
nucleic acid binding by the HPLC-purified CTE gave comparable results (data not shown).
Conserved Residues in the CTE of Yeast TERT Are Required for
Telomerase Activity and Processivity--
Even though the CTEs of
TERTs do not exhibit significant sequence similarity to retroviral RTs,
they appear to be loosely conserved as a group (29). To determine
whether the sequence conservation has functional significance, we
mutated conserved residues within the CTE of yeast TERT and tested the
resulting enzyme for defects both in vivo and in
vitro. A total of five mutants with substitutions in
conserved residues (SCR mutants) were made,
each with two or three consecutive residues changed to alanines:
LF759AA, TID768AAA, NS774AA, YK794AA, FL847AA (with the number
designating the position of the first amino acid residue in each pair
or triplet; Fig. 5A). For
comparison, a mutant with substitutions in non-conserved residues was
also made (CD831AA). Each mutant was tagged at the C terminus with
tandem copies of the IgG-binding domain of proteins A, placed on a
centromeric plasmid, and used to transform a yeast strain whose
chromosomal EST2 (TERT) gene has been disrupted. A similarly tagged
wild type EST2 gene was analyzed in parallel as the control.
All of the strains were first tested for telomere length defects. As
shown in Fig. 5B, all five SCR mutants exhibited varying degrees of telomere shortening, whereas the CD831AA mutant did not. The
most defective SCR mutants (TID768AA, NS774AA, and YK794AA) have
telomeres that are indistinguishable from the C745 truncation mutant,
suggesting that these substitutions have completely abolished the
function of CTE in vivo.
To determine whether the telomere maintenance defects can be explained
by telomerase activity loss or alteration, we purified protein A-tagged
telomerase from the wild type and mutant strains by IgG-Sepharose and
subjected it to primer extension assays (Fig. 6A). The results were analyzed
both in terms of the overall levels of DNA synthesis (Fig.
6B) and the processivity of nucleotide addition (Fig.
6C). As expected, the CD831AA mutant exhibited a nearly
normal level of telomerase activity and a normal pattern of extension,
consistent with its ability to maintain normal telomere lengths. In
contrast, all of the SRC mutants suffered either a loss of total
activity, a significant reduction in enzyme processivity, or both.
Interestingly, the two mutants with total activity loss but no evident
processivity defect (LF759AA and FL847AA) manifested relatively modest
telomere shortening such that the levels of activity correlated with
the lengths of telomeres. On the other hand, the three
mutants with substantial processivity defects (TID768AAA, NS774AA, and
YK794AA) all manifested severe telomere shortening. Of the three, only
the YK794AA mutant suffered substantial loss of total activity
(>10-fold). These results are in accordance with earlier studies and
indicate that both the total activity and the processivity of
telomerase are important determinants of telomere lengths. Processivity
appears to be the more dominant factor, because only a modest reduction
in processivity was sufficient to trigger severe telomere
shortening (29).
The substantial loss of overall activity exhibited by the YK794AA and
the FL847AA mutants are surprising in light of previous analysis of the
C745 truncation mutant, which has no CTE yet suffers only a modest
reduction in overall activity. To determine the basis for the activity
loss manifested by the substitutions mutants, we quantified the levels
of Est2p and Est2p-associated TLC1 RNA (yeast telomerase RNA) in wild
type and mutant strains. As shown in Fig.
7, A and B, both
the YK794AA and FL847AA mutants have much lower levels of Est2p and
Est2p-associated TLC1 RNA in cell extracts, whereas the other mutants
have very few defects in this regard. Quantitation indicates that the
magnitude of reduction for both RNA and protein was ~4-10-fold (data
not shown). These results suggest that substitution in some conserved
CTE residues can impair protein stability (possibly by causing protein
misfolding), thereby leading to a reduction in the level of telomerase
ribonucleoprotein.
The Function of the C-terminal Extension of Telomerase Reverse
Transcriptase--
We have shown in this and an earlier study (29)
that the CTE of yeast TERT is required for optimal telomerase
processivity and stable telomerase-DNA binding. The yeast CTE also
possesses a nucleic acid binding activity when recombinantly
overexpressed and purified. These results support the notion that
despite the lack of sequence similarity between CTE and the thumb
domain of conventional RTs, the CTE of TERT may nevertheless act as a
thumb for telomerase.
A precedent for sequence divergence coupled with functional (and
potential structural) similarity was noted in structural comparison of
the thumbs of HIV-1 RT and HCV RNA-dependent RNA polymerase
(41). Although both thumbs are believed to contact and help encircle
the nucleic acids, they do not show significant sequence homology.
Structurally, the HCV domain is much larger with seven instead of three
helices. Nevertheless, a modeling exercise suggests that one of the HCV
thumb helices (helix P) may have the same disposition relative to
nucleic acids as an HIV-1 helix (helix H), which has been shown to be
important for substrate interactions (41, 42). Results of our CD
analysis provide tantalizing support for the existence of a comparable helix in the CTE of TERTs. Clearly, high-resolution structural analysis
of CTE will be required to address this possibility.
Telomerase from several species has been shown to form dimers/multimers
in vitro and in vivo, although the subunit or
domain of the complex responsible for dimerization is not well
characterized. The functional significance of dimerization also remains
to be determined. The monomeric behavior of the yeast CTE in solution suggests that this domain cannot be the sole determinant of
dimerization. This is in agreement with a recent analysis of hTERT,
which also fails to detect a homotypic interaction of its CTE domain
(43).
Potential Sequence and Functional Conservation among the CTEs of
TERTs--
Deletion analysis of CTE in different organisms yielded
somewhat disparate results. Removal of part or all of the CTE of the Tetrahymena and human TERT was found to result in a
completely inactive telomerase in either in vitro or
in vivo reconstitution assays (44-46). In contrast, as we
have demonstrated in this and an earlier study, removal of the entire
CTE of yeast TERT resulted in a catalytically active telomerase with
greatly reduced processivity (29). This discrepancy raises the
possibility that the CTEs of different TERTs may perform fundamentally
different functions. However, this possibility would appear to be
contradicted by our mutagenesis studies, which indicate that conserved
CTE residues identified by sequence alignment are indeed functionally
important, either for protein stability or telomerase processivity.
How might the different deletion analysis results be reconciled? Two
hypotheses may be considered. First, we have shown that several partial
deletions of yeast CTE and amino acid substitution of conserved CTE
residues can lead to greatly diminished TERT levels in cell extracts,
suggesting that these mutations cause protein misfolding and
destabilization (29). It is possible that partial deletions of the
Tetrahymena and human CTE can have similar deleterious
effects. Second, the nucleic acid binding function of the CTE may be
more or less essential for telomerase activity, depending on the
presence of other nucleic acid binding modules/domains in the enzyme
complex. For example, the yeast telomerase reconstituted in
vivo may possess other nucleic acid binding components that can
partially compensate for the loss of CTE. In this regard, it is
interesting to note that Est1p, a non-catalytic component of yeast
telomerase, has been shown to possess a single-stranded telomeric DNA
binding activity (47, 48). Another distinguishing feature of the yeast
enzyme is its relatively long RNA template (17 nucleotides instead of 9 or 10 nucleotides for the Tetrahymena and human RNA), which
can presumably bind more strongly to the DNA primer and possibly
alleviate the consequence of CTE loss.
Although our evidence favors at least one conserved function for CTE,
it by no means rules out some additional species-specific functions
such as interaction with other components of the telomerase holoenzyme.
In particular, the addition of an epitope tag to the C terminus of
hTERT resulted in a catalytically active telomerase that is unable to
maintain telomeres in vivo, a finding that argues for just
such a species-specific function (49).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-helices, part of which makes direct contact with the
template/primer duplex (32). The comparable region of TERTs (henceforth
referred to as the CTE for C-terminal
extension) exhibits no evident sequence homology to
retroviral RTs. However, previous work from our laboratory indicates
that the CTE of yeast TERT (Est2p) is also required for optimal enzyme
processivity, raising the possibility that the CTE may also constitute
a thumb for telomerase. In this report, we explored the mechanistic
basis for the function of telomerase CTE and found that it enhances the
stability of telomerase-DNA interaction both before and after
polymerization. The CTE of Est2p also possesses a nucleic acid binding
activity when recombinantly expressed and purified.
Finally, the CTEs of TERTs as a group appear to exhibit a low level of
sequence conservation, and substitution of quite a few conserved CTE
residues in Est2p was found to impair telomerase activity and
processivity. Taken together, our study supports the notion that the
CTE of TERT has a conserved function in promoting primer binding and
telomerase processivity and that mechanistic similarity between
telomerase and conventional RTs may be greater than indicated by
apparent sequence similarity.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
est2 strain harboring the pSE-Est2-C874 plasmid (containing a
protein A-tagged EST2 gene) has been described (33). This fully
functional Est2p is designated as wild type telomerase throughout the
text. The construction of the protein A-tagged C745 mutant has been
described also (29). All substitution mutations in the CTE of EST2 were
generated using the QuikChange protocol (Stratagene), appropriate
primer oligonucleotides, and pSE-Est2-C874 as template. All point
mutations were confirmed by sequencing. The oligodeoxynucleotide
primers used for telomerase assays were purchased from Sigma and
purified by denaturing gel electrophoresis prior to use. The primers
have the following sequences: TEL15(m12), TGTCTGGTGTGTGGG;
TEL24, TGTGTGGGTGTGTGGGTGTGTGGG; TEL66, TAGGGTAGTAGTAGGG.
-32P]dTTP (3000 Ci/mmol). The reactions were stopped
after 6 min, a time point within the linear range of DNA synthesis. The
Km (for the primer) and Vmax
values were determined by obtaining least square fitting lines of the
data in Eadie-Hofstee plots and then calculating the inverse of the
negative slope and x-intercept, respectively.
-D-thiogalactopyranoside to 0.1 mM, and grown at 17 °C for 16 h. The cells
were harvested, and extracts were prepared by sonication. The
CTE-containing fusion protein was bound to Chitin resin according to
the manufacturer's instructions and then cleaved by incubating the
resin in 50 mM dithiothreitol at room temperature for
16 h. The free CTE was eluted with 25 mM Tris·HCl,
pH 8.0, 8 M urea and then was further enriched by either
reverse phase HPLC or S-Sepharose. The HPLC purification was carried
out on a Vydac C-4 preparative column (Hesperia, CA) using a
water-acetonitrile gradient in the presence of 0.1% trifluoroacetic
acid (37). The resulting preparation was lyophilized and solubilized in
water. The S-Sepharose chromatography involved binding of free CTE
to a column followed by elution with 25 mM Tris·HCl, pH
8.0, 8 M urea, 1 M NaCl. The resulting
preparation was dialyzed stepwise into buffers containing lower
concentrations of urea and NaCl until both were removed completely.
]222 were performed at 0 °C in 50 mM sodium phosphate, pH 7.0, and 150 mM NaCl (37). Analytical ultracentrifugation measurements
were carried out on a Beckman XL-A (Beckman Coulter) analytical
ultracentrifuge using an An-60 Ti rotor (Beckman Coulter) (38).
Filter-binding assays were carried out as described previously
(33).
-32P]GTP as described (39). The levels of Est2p in
cell extracts were determined by Western analysis as described
previously (30).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (21K):
[in a new window]
Fig. 1.
The C-terminal extension of Est2p enhances
the stability of telomerase-DNA interaction. A, a schematic
illustration of the structure of Est2p showing the locations of the
conserved RT motifs, the N-terminal extension, and the C-terminal
extension. B, wild type and C745 telomerase were subjected
to the primer challenge protocol as described under "Materials and
Methods." Products arising from extension of either TEL24 or
TEL15(m12) are indicated by brackets to the left
of the panel. The time intervals (in min) between the addition of the
TEL24 primer and the nucleotides are indicated at the top.
C, the signals for the test primer (TEL15(m12)) were
normalized against the signal obtained in the absence of the
challenge primer (TEL24) and plotted as a function of time.

View larger version (31K):
[in a new window]
Fig. 2.
The C745 telomerase binds less stably to its
extension products. A, duplicate primer extension assays
were carried out using a telomeric oligonucleotide,
[32P]dGTP, dTTP, and either wild type or C745 telomerase.
Upon termination, the products were separated into free
(Free) and enzyme-bound (Bound) fractions and
analyzed by a denaturing gel. The location of the primer + 3 (+3) product is marked by horizontal lines to the
left and right of the panel. B, the
ratios of enzyme-bound to free product for the primer + 3 (p + 3) and primer + 5 (p + 5) products
synthesized by both the wild type and C745 enzyme are plotted.

View larger version (33K):
[in a new window]
Fig. 3.
The C745 telomerase exhibits an increased
Km for a telomeric primer. A, primer extension
assays were carried out using varying concentrations of a telomeric
primer (0.17, 0.34, 0.67, 1.3, and 2.6 µM) and either
wild type or C745 telomerase. Reactions were terminated at 6 min (a
time point within the linear range of product accumulation), and the
products were analyzed by a denaturing gel. B, Eadie-Hofstee
plots of the results obtained for the wild type and C745 telomerase.
The derived Km and Vmax
values for both enzymes are listed at the right.
-helical content (data not shown).
Thus, despite the denaturation step during isolation, the purified CTE
appears to be well folded.

View larger version (23K):
[in a new window]
Fig. 4.
The CTE of Est2p possesses a nucleic acid
binding activity. A, the CTE purified by either an S or HPLC
column was analyzed by SDS-PAGE and stained with Coomassie Brilliant
Blue. B, the CTE (purified by an S column) and
Maltose-binding protein (MBP) were tested for binding to 1 nM of a single-stranded telomeric oligonucleotide
(TGTGTGGGTGTGTGGGTGTGTGGG), and the results were plotted. C,
the CTE (purified by an S column, 4 µg) was tested for binding to 1 nM of three different substrates. The single strand DNA is
a 15-mer oligonucleotide with a telomere-like sequence
(TGTGTGGTGTGTGGG). The double strand DNA and RNA-DNA hybrid were
generated by annealing the same oligonucleotide to fully complementary
DNA and RNA oligomers, respectively. The background was subtracted from
the signals and the results plotted.

View larger version (42K):
[in a new window]
Fig. 5.
Conserved residues in the CTE of Est2p are
required for telomere maintenance. A, a schematic
illustration of the CTE of Est2p showing conserved regions and the
residues chosen for mutagenesis. There are apparently two moderately
conserved blocks as indicated by gray bars. The locations of
five mutants with substitutions in conserved residues are indicated by
filled boxes, and that of the single mutant with
substitutions in non-conserved residues is indicated by an open
box. For a detailed alignment of CTEs see Ref. 29. B,
telomere lengths were determined for strains bearing either wild type
or mutated Est2ps. The identities of the Est2ps in the strains are
indicated at the top of the panel. The locations of the
Y'-type telomeres and an X-type telomere are indicated by
brackets to the left of the panel.

View larger version (27K):
[in a new window]
Fig. 6.
Conserved residues in the CTE of Est2p are
required for either telomerase activity or processivity. A,
telomerase from the wild type and various mutant strains was isolated
by IgG affinity chromatography and tested in primer extension assays
using TEL66 primer, [32P]dGTP, and dTTP. The identities
of the mutations are indicated at the top, and the location
of the primer + 3 (+3) product is indicated by a
horizontal line at the left. An RNase-insensitive
band (indicated by an asterisk) can sometimes be observed in
these assays, presumably because of a contaminating activity.
B, total DNA synthesis mediated by the mutant enzymes was
determined in duplicate assays and normalized against that by the wild
type enzyme, and the results were plotted. C, the
processivity of the wild type and mutant enzymes for the primer + 3 (+3) and the primer + 4 (+4) positions were
determined in duplicate assays, and the results were plotted.

View larger version (45K):
[in a new window]
Fig. 7.
Two mutations in CTE significantly reduced
the levels of Est2p and Est2p-associated telomerase RNA. A,
levels of protein A-tagged Est2p in the wild type and mutant strains
were determined by Western-blotting using antibodies directed against
protein A. B, the levels of Est2p-associated TLC1 RNA in the
wild type and mutant strains were determined by RNase protection
assays. The position of the protected TLC1 fragment is indicated by an
arrow on the right.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Min Lu for the CD and equilibrium centrifugation analysis and members of the Lue lab for reading and commenting on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by an American Cancer Society research project grant, the Tartikoff/Perelman/EIF Fund from the Academic Medicine Development Company, and an RO1 grant from the National Institutes of Health. The Department of Microbiology and Immunology was supported by the William Randolph Hearst Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 212-746-6506;
Fax: 212-746-8587; E-mail: nflue@mail.med.cornell.edu.
Published, JBC Papers in Press, July 31, 2002, DOI 10.1074/jbc.M201976200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RT, reverse transcriptase; CTE, C-terminal extension; HPLC, high pressure liquid chromatography; CD, circular dichroism; SCR, substitutions in conserved residues; TERT, telomerase reverse transcriptase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Greider, C. W., and Blackburn, E. H. (1985) Cell 43, 405-413[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Greider, C. W., and Blackburn, E. H. (1989) Nature 337, 331-337[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Blackburn, E. H. (1992) Ann. Rev. Biochem. 61, 113-129[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Nugent, C. I.,
and Lundblad, V.
(1998)
Genes Dev.
12,
1073-1085 |
| 5. |
Tzfati, Y.,
Fulton, T. B.,
Roy, J.,
and Blackburn, E. H.
(2000)
Science
288,
863-867 |
| 6. | Chen, J. L., Blasco, M. A., and Greider, C. W. (2000) Cell 100, 503-514[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Lendvay, T. S., Morris, D. K., Sah, J., Balasubramanian, B., and Lundblad, V. (1996) Genetics 144, 1399-1412[Abstract] |
| 8. |
Lingner, J.,
and Cech, T. R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10712-10717 |
| 9. |
Lingner, J.,
Hughes, T. R.,
Shevchenko, A.,
Mann, M.,
Lundblad, V.,
and Cech, T. R.
(1997)
Science
276,
561-567 |
| 10. |
Nakamura, T. M.,
Morin, G. B.,
Chapman, K. B.,
Weinrich, S. L.,
Andrews, W. H.,
Lingner, J.,
Harley, C. B.,
and Cech, T. R.
(1997)
Science
277,
955-959 |
| 11. | Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoof, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. (1997) Cell 90, 785-795[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Kilian, A.,
Bowtell, D. D.,
Abud, H. E.,
Hime, G. R.,
Venter, D. J.,
Keese, P. K.,
Duncan, E. R.,
Reddel, R. R.,
and Jefferson, R. A.
(1997)
Hum. Mol. Genet.
6,
2011-2019 |
| 13. |
Bryan, T. M.,
Sperger, J. M.,
Chapman, K. B.,
and Cech, T. R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8479-8484 |
| 14. |
Collins, K.,
and Gandhi, L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8485-8490 |
| 15. | Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B., and DePinho, R. A. (1998) Oncogene 16, 1723-1730[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Oguchi, K., Liu, H., Tamura, K., and Takahashi, H. (1999) FEBS Lett. 457, 465-469[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Fitzgerald, M. S.,
Riha, K.,
Gao, F.,
Ren, S.,
McKnight, T. D.,
and Shippen, D. E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14813-14818 |
| 18. | Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. (1997) Nat. Genet. 17, 198-502[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Beattie, T. L., Zhou, W., Robinson, M. O., and Harrington, L. (1998) Curr. Biol. 8, 177-180[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Collins, K., Kobayashi, R., and Greider, C. W. (1995) Cell 81, 677-686[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Gandhi, L.,
and Collins, K.
(1998)
Genes Dev.
12,
721-733 |
| 22. |
Harrington, L.,
McPhail, T.,
Mar, V.,
Zhou, W.,
Oulton, R.,
Program, A. E.,
Bass, M. B.,
Arruda, I.,
and Robinson, M. O.
(1997)
Science
275,
973-977 |
| 23. | Nakayama, J.-I., Saito, M., Nakamura, H., Matsuura, A., and Ishikawa, F. (1997) Cell 88, 875-884[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Holt, S. E.,
Aisner, D. L.,
Baur, J.,
Tesmer, V. M., Dy, M.,
Ouellette, M.,
Trager, J. B.,
Morin, G. B.,
Toft, D. O.,
Shay, J. W.,
Wright, W. E.,
and White, M. A.
(1999)
Genes Dev.
13,
817-826 |
| 25. |
Counter, C. M.,
Meyerson, M.,
Eaton, E. N.,
and Weinberg, R. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9202-9207 |
| 26. |
Harrington, L.,
Zhou, W.,
McPhail, T.,
Oulton, R.,
Yeung, D. S. K.,
Mar, V.,
Bass, M. B.,
and Robinson, M. O.
(1997)
Genes Dev.
11,
3109-3115 |
| 27. |
Haering, C. H.,
Nakamura, T. M.,
Baumann, P.,
and Cech, T. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6367-6372 |
| 28. |
Bryan, T. M.,
Goodrich, K. J.,
and Cech, T. R.
(2000)
J. Biol. Chem.
275,
24199-24207 |
| 29. | Peng, Y., Mian, I. S., and Lue, N. F. (2001) Mol. Cell 7, 1201-1211[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Bosoy, D.,
and Lue, N.
(2001)
J. Biol. Chem.
276,
46305-46312 |
| 31. | Miller, M. C., Liu, J. K., and Collins, K. (2000) EMBO J. 19, 4412-4422[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Huang, H.,
Chopra, R.,
Verdine, G. L.,
and Harrison, S. C.
(1998)
Science
282,
1669-1675 |
| 33. |
Xia, J.,
Peng, Y.,
Mian, I. S.,
and Lue, N. F.
(2000)
Mol. Cell. Biol.
20,
5196-5207 |
| 34. |
Cohn, M.,
and Blackburn, E. H.
(1995)
Science
269,
396-400 |
| 35. |
Lue, N. F.,
and Peng, Y.
(1998)
Nucleic Acids Res.
26,
1487-1494 |
| 36. |
Lue, N. F.,
and Xia, J.
(1998)
Nucleic Acids Res.
26,
1495-1502 |
| 37. | Shu, W., Ji, H., and Lu, M. (1999) Biochemistry 38, 5378-5385[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Laue, T. M., Shah, B. D., Ridgeway, T. M., and Pelletier, S. L. (1992) in Analytical Ultracentrifugation in Biochemistry and Polymer Science. (Harding, S. E. , Rowe, A. J. , and Horton, J. C., eds) , pp. 90-125, Royal Society of Chemistry, Cambridge |
| 39. |
Lue, N. F.,
and Kornberg, R. D.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
8839-8843 |
| 40. |
Singer, M. S.,
and Gottschling, D. E.
(1994)
Science
266,
404-409 |
| 41. |
Bressanelli, S.,
Tomei, L.,
Roussel, A.,
Incitti, I.,
Vitale, R.,
Mathieu, M., De, F. R.,
and Rey, F.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13034-13039 |
| 42. |
Bebenek, K.,
Beard, W. A.,
Casas-Finet, J. R.,
Kim, H. R.,
Darden, T. A.,
Wilson, S. H.,
and Kunkel, T. A.
(1995)
J. Biol. Chem.
270,
19516-19523 |
| 43. | Arai, K., Masutomi, K., Khurts, S., Kaneko, S., Kobayashi, K., and Murakami, S. (2002) J. Biol. Chem., in press |
| 44. |
Bachand, F.,
and Autexier, C.
(2001)
Mol. Cell. Biol.
21,
1888-1897 |
| 45. |
Lai, C. K.,
Mitchell, J. R.,
and Collins, K.
(2001)
Mol. Cell. Biol.
21,
990-1000 |
| 46. |
Beattie, T. L.,
Zhou, W.,
Robinson, M. O.,
and Harrington, L.
(2000)
Mol. Biol. Cell
11,
3329-3340 |
| 47. |
Virta-Pearlman, V.,
Morris, D. K.,
and Lundblad, V.
(1996)
Genes Dev.
10,
3094-3104 |
| 48. |
Zhou, J.,
Hidaka, K.,
and Futcher, B.
(2000)
Mol. Cell. Biol.
20,
1947-1955 |
| 49. |
Counter, C. M.,
Hahn, W. C.,
Wei, W.,
Caddle, S. D.,
Beijersbergen, R. L.,
Lansdorp, P. M.,
Sedivy, J. M.,
and Weinberg, R. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14723-14728 |
This article has been cited by other articles:
![]() |
S. N. Finger and T. M. Bryan Multiple DNA-binding sites in Tetrahymena telomerase Nucleic Acids Res., March 27, 2008; 36(4): 1260 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. M. Wyatt, D. A. Lobb, and T. L. Beattie Characterization of Physical and Functional Anchor Site Interactions in Human Telomerase Mol. Cell. Biol., April 15, 2007; 27(8): 3226 - 3240. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-T. Xin, A. D. Beauchamp, R. T. Calado, J. W. Bradford, J. A. Regal, A. Shenoy, Y. Liang, P. M. Lansdorp, N. S. Young, and H. Ly Functional characterization of natural telomerase mutations found in patients with hematologic disorders Blood, January 15, 2007; 109(2): 524 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Middleman, J. Choi, A. S. Venteicher, P. Cheung, and S. E. Artandi Regulation of Cellular Immortalization and Steady-State Levels of the Telomerase Reverse Transcriptase through Its Carboxy-Terminal Domain. Mol. Cell. Biol., March 1, 2006; 26(6): 2146 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. MORIARTY, D. T. MARIE-EGYPTIENNE, and C. AUTEXIER Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase RNA, September 1, 2005; 11(9): 1448 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Lue A Physical and Functional Constituent of Telomerase Anchor Site J. Biol. Chem., July 15, 2005; 280(28): 26586 - 26591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moriarty, R. J. Ward, M. A.S. Taboski, and C. Autexier An Anchor Site-Type Defect in Human Telomerase That Disrupts Telomere Length Maintenance and Cellular Immortalization Mol. Biol. Cell, July 1, 2005; 16(7): 3152 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moriarty, D. T. Marie-Egyptienne, and C. Autexier Functional Organization of Repeat Addition Processivity and DNA Synthesis Determinants in the Human Telomerase Multimer Mol. Cell. Biol., May 1, 2004; 24(9): 3720 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bosoy and N. F. Lue Yeast telomerase is capable of limited repeat addition processivity Nucleic Acids Res., January 2, 2004; 32(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Lue, Y.-C. Lin, and I. S. Mian A Conserved Telomerase Motif within the Catalytic Domain of Telomerase Reverse Transcriptase Is Specifically Required for Repeat Addition Processivity Mol. Cell. Biol., December 1, 2003; 23(23): 8440 - 8449. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huard, T. J. Moriarty, and C. Autexier The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Singh and N. F. Lue Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: Evidence in support of an activating function PNAS, May 13, 2003; 100(10): 5718 - 5723. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||